149 related articles for article (PubMed ID: 9738584)
1. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
Linderholm B; Tavelin B; Grankvist K; Henriksson R
J Clin Oncol; 1998 Sep; 16(9):3121-8. PubMed ID: 9738584
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
3. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
[TBL] [Abstract][Full Text] [Related]
5. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
Linderholm B; Tavelin B; Grankvist K; Henriksson R
Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
[TBL] [Abstract][Full Text] [Related]
6. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
[TBL] [Abstract][Full Text] [Related]
7. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
[TBL] [Abstract][Full Text] [Related]
8. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
10. The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer.
Wen XF; Shen Z; Shen ZZ; Nguyen M; Shao ZM
Oncol Rep; 2002; 9(5):937-44. PubMed ID: 12168051
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
Manders P; Beex LV; Tjan-Heijnen VC; Geurts-Moespot J; Van Tienoven TH; Foekens JA; Sweep CG
Br J Cancer; 2002 Sep; 87(7):772-8. PubMed ID: 12232762
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
Jacobsen J; Rasmuson T; Grankvist K; Ljungberg B
J Urol; 2000 Jan; 163(1):343-7. PubMed ID: 10604387
[TBL] [Abstract][Full Text] [Related]
13. Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer.
Coradini D; Boracchi P; Daidone MG; Pellizzaro C; Miodini P; Ammatuna M; Tomasic G; Biganzoli E
Br J Cancer; 2001 Sep; 85(6):795-7. PubMed ID: 11556826
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and prognosis of cervical carcinoma.
Cheng WF; Chen CA; Lee CN; Wei LH; Hsieh FJ; Hsieh CY
Obstet Gynecol; 2000 Nov; 96(5 Pt 1):721-6. PubMed ID: 11042307
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.
Manders P; Sweep FC; Tjan-Heijnen VC; Geurts-Moespot A; van Tienoven DT; Foekens JA; Span PN; Bussink J; Beex LV
Clin Cancer Res; 2003 Dec; 9(17):6363-70. PubMed ID: 14695136
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.
Smith BD; Smith GL; Carter D; Sasaki CT; Haffty BG
J Clin Oncol; 2000 May; 18(10):2046-52. PubMed ID: 10811669
[TBL] [Abstract][Full Text] [Related]
17. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival.
Chen CA; Cheng WF; Lee CN; Wei LH; Chu JS; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Feb; 80(2):207-12. PubMed ID: 11161861
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
